DANIEL PENNY to Longitudinal Studies
This is a "connection" page, showing publications DANIEL PENNY has written about Longitudinal Studies.
Connection Strength
0.069
-
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation. J Am Heart Assoc. 2025 Apr; 14(7):e038061.
Score: 0.043
-
Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial. Am Heart J. 2018 07; 201:1-8.
Score: 0.026